There are 300 GcMAF scientists from eight nations who have written nearly 150 scientific research papers on GcMAF, all of them peer reviewed and published in the world’s top scientific journals.
Just over half of them are republished on the US National Library of Medicine, or Pubmed.
If you go to a US government website, https://www.ncbi.nlm.nih.gov/pubmed, and do a search on gcmaf or dbpmaf, you’ll see 66 of the 78 GcMAF papers published there.
One of my favourites is Vitamin D Binding Protein-Macrophage Activating Factor Inhibits HCC in SCID Mice – that is the full title for GcMAF, which is a human protein with no side effects. Its authors are Japan’s top five cancer research institutes, including the prestigious Atomic Bomb Institute, Nagasaki University.
They know more about cancer than anyone.
On page 4 they show a photo of cancer tumours shrunk 90 per cent in three weeks by GcMAF.
Eleven thousand human patients have now been treated, so we do have good scientific data.
I myself am a co-author of 10 GcMAF research papers on results in the laboratory and in patients. One is Oleic Acid, Deglycosylated Vitamin D-Binding Protein, Nitric Oxide: A Molecular Triad Made Lethal to Cancer where we show patient scans of tumours reduced 25 per cent in a week with GcMAF.
I am fed up with the BBC, Cancer Research UK, and the MHRA not acknowledging the scientific evidence for GcMAF, particularly when so many of us have put decades of hard work into providing a plethora of evidence.
Biomedical scientist, Farnham Road, Bournemouth